2024-04-01 13196167 2025-03-31 13196167 2024-04-01 2025-03-31 13196167 2024-03-31 13196167 2023-04-01 2024-03-31 13196167 uk-core:WithinOneYear 2024-03-31 13196167 uk-core:WithinOneYear 2025-03-31 13196167 uk-bus:Director1 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure 13196167 uk-bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13196167 uk-bus:Micro-entities 2024-04-01 2025-03-31 13196167 uk-bus:FullAccounts 2024-04-01 2025-03-31 13196167 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31

MK Therapies Limited

Registered Number:13196167

For the year ended 31 March 2025
England and Wales
Unaudited Financial Statements

2
For the year ended 31 March 2025
MK Therapies Limited
Contents Page
1 to 2
Statement of Financial Position and Notes to the Accounts
3

13196167

Registered Number :

As at 31 March 2025

MK Therapies Limited
Statement of Financial Position and Notes to the Accounts

£

£

2024
2025

£

£

13,903
6,135

Current assets

Creditors: amounts falling due

within one year

(5,857)
(5,658)
278
8,245
Net current assets

Total assets less current liabilities

8,245
278
8,245
Net assets
278
8,245
278

Capital and reserves

Notes to the Accounts

Statutory Information

MK Therapies Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 13196167.

Registered address:

41 Walsingham Road
London
EN2 6EY

The presentation currency is £ sterling.

1. Directors' advances, credits and guarantees

During the year, the company made advances to a director amounting to £5,210 which was written off as dividends
within 9 months after the year end.

2. Average number of persons employed

During the year the average number of employees was 1 (2024 : 1)
1 of 2
4

13196167

Registered Number :

For the year ended 31 March 2025
MK Therapies Limited
Statement of Financial Position and Notes to the Accounts Continued

For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Matthew Kent Director

These financial statements were approved and authorised for issue by the Board on 13 November 2025 and were signed by:

2 of 2